Valsartan: A Review of its Use in Patients with Heart Failure and/or Left Ventricular Systolic Dysfunction After Myocardial Infarction

By Katherine F. Croom   Gillian M. Keating  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-404

Adis International

Access to resources Recommend Favorite

Should the aldosterone-receptor antagonist – eplerenone – be used after acute myocardial infarction with left ventricular dysfunction?

By Doggrell Sheila  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1605-1607

Informa Healthcare

Access to resources Recommend Favorite

Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure

By Croom Katherine F.   Plosker Greg L.  

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1057-1072

Adis International

Access to resources Recommend Favorite

The treatment of chronic heart failure due to left ventricular systolic dysfunction

By Gardner R S   McDonagh T A  

Clinical Medicine, Vol. 4, Iss. 1, 2004-01 ,pp. : 18-22

Royal College Of Physicians

Access to resources Recommend Favorite

Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers: Subanalysis of the EPHESUS

By Zhang Zefeng   Mahoney Elizabeth M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite